Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.
Calabresi PA, Fields NS, Maloni HW, Hanham A, Carlino J, Moore J, Levin MC, Dhib-Jalbut S, Tranquill LR, Austin H, McFarland HF, Racke MK.
Calabresi PA, et al. Among authors: hanham a.
Neurology. 1998 Jul;51(1):289-92. doi: 10.1212/wnl.51.1.289.
Neurology. 1998.
PMID: 9674825
Clinical Trial.